IceCure Medical (ICCM) Accounts Payables (2020 - 2026)

IceCure Medical (ICCM) has reported Accounts Payables for 7 consecutive years, with $1.6 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables rose 40.74% year-over-year to $1.6 million in Q2 2026; TTM through Jun 2026 was $1.6 million, a 40.74% increase from a year earlier, with the FY2025 full-year figure at $863000.0, down 29.95% from the prior year.
• Accounts Payables was $1.6 million for Q2 2026 at IceCure Medical, up from $988000.0 in the prior quarter.
• Over five years, Accounts Payables peaked at $1.6 million in Q2 2026 and troughed at $502000.0 in Q4 2023.
• A 5-year average of $915277.8 and a median of $900000.0 in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables sank 30.42% in 2023 and soared 145.42% in 2024, its largest moves.
• Over 5 years, Accounts Payables stood at $714000.0 in 2022, then declined by 29.69% to $502000.0 in 2023, then soared by 145.42% to $1.2 million in 2024, then dropped by 29.95% to $863000.0 in 2025, then surged by 89.34% to $1.6 million in 2026.
• The last three Accounts Payables figures came in at $1.6 million (Q2 2026), $988000.0 (Q1 2026), and $863000.0 (Q4 2025), per Business Quant data.